U.S. markets closed
  • S&P 500

    4,455.48
    +6.50 (+0.15%)
     
  • Dow 30

    34,798.00
    +33.20 (+0.10%)
     
  • Nasdaq

    15,047.70
    -4.50 (-0.03%)
     
  • Russell 2000

    2,248.07
    -10.97 (-0.49%)
     
  • Crude Oil

    73.95
    +0.65 (+0.89%)
     
  • Gold

    1,750.60
    +0.80 (+0.05%)
     
  • Silver

    22.42
    -0.26 (-1.16%)
     
  • EUR/USD

    1.1718
    -0.0029 (-0.25%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • GBP/USD

    1.3661
    -0.0059 (-0.43%)
     
  • USD/JPY

    110.6590
    +0.3580 (+0.32%)
     
  • BTC-USD

    43,266.26
    +558.01 (+1.31%)
     
  • CMC Crypto 200

    1,067.20
    -35.86 (-3.25%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,248.81
    +609.41 (+2.06%)
     

Oncology Pipeline Database 2021: Indication; Clinical Trial Stages; Drug Mechanism Classes; Competitive Landscape - ResearchAndMarkets.com

·2 min read

DUBLIN, September 14, 2021--(BUSINESS WIRE)--The "Oncology Pipeline Database - 2021" report has been added to ResearchAndMarkets.com's offering.

Oncology Pipeline Highlights Database - 2021, provides the most up-to-date information on key pipeline products in the global Oncology Drug market.

It covers emerging therapies for Oncology indications in active clinical development stages including early and late-stage clinical trials. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin's disease, Acute Myeloid Leukemia and Multiple Myeloma. The pipeline data is presented in an excel dashboard with filtering options.

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:

The database presents pipeline by Oncology indications. Key indications covered in this database include Esophageal Cancer Stomach Cancer, Colon Cancer, Pancreatic Cancer, Malignant Melanoma, Breast Cancer, Cervical Cancer, Ovary Cancer, Prostate Cancer, Renal Cancer, Bladder Cancer, Brain Cancer, Hodgkin's disease, Acute Myeloid Leukemia and Multiple Myeloma.

By Clinical Trial Stages:

The database provides Oncology pipeline products by clinical trial stages including both early and late-stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:

The database provides Oncology pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

By Company:

The database provides Oncology pipeline products by the company.

SUMMARY:

  • Oncology Pipeline by Indication

  • Oncology Pipeline by Clinical Trial Phase

  • Oncology Pipeline by Drug Mechanism Classes

  • Oncology Pipeline by Company

For more information about this report visit https://www.researchandmarkets.com/r/c6c2cq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210914005751/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900